{"entity":{"type":"insider","cik":"0001614073","url":"/insider/0001614073","json_url":"/insider/0001614073.json","name":"TRV GP II, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":13,"first":"2016-05-18","last":"2021-06-07","span_basis":"filed_date"},"name_variants":[{"name":"TRV GP II, LLC","source":"filing","n_filings":13,"first_seen":"2016-05-18","last_seen":"2021-06-07"}],"transactions":[{"id":4661533,"accession":"0000899243-21-022345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-022345","line_url":"/filing/0000899243-21-022345#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP II, LLC; TEPPER ROBERT I; STARR KEVIN P; Third Rock Ventures II, L.P.; LEVIN MARK J; Third Rock Ventures GP II, L.P.","owner_display_name":"TRV GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":164996.0,"shares_display":"164,996","price_per_share":30.23,"price_display":"30.23","price_state":"stated","total_value":4987829.08,"total_display":"4,987,829.08","total_whole":"4,987,829","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":4661528,"accession":"0000899243-21-022345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-022345","line_url":"/filing/0000899243-21-022345#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP II, LLC; TEPPER ROBERT I; STARR KEVIN P; Third Rock Ventures II, L.P.; LEVIN MARK J; Third Rock Ventures GP II, L.P.","owner_display_name":"TRV GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":378117.0,"shares_display":"378,117","price_per_share":30.2,"price_display":"30.20","price_state":"stated","total_value":11419133.4,"total_display":"11,419,133.40","total_whole":"11,419,133","shares_owned_after":164996.0,"shares_owned_after_display":"164,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-07","scope":"insider"},{"id":5131915,"accession":"0000899243-21-020885","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-020885","line_url":"/filing/0000899243-21-020885#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"STARR KEVIN P; TEPPER ROBERT I; LEVIN MARK J; Third Rock Ventures GP II, L.P.; Third Rock Ventures II, L.P.; TRV GP II, LLC","owner_display_name":"STARR KEVIN P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1231204.0,"shares_display":"1,231,204","price_per_share":30.53,"price_display":"30.53","price_state":"stated","total_value":37588658.12,"total_display":"37,588,658.12","total_whole":"37,588,658","shares_owned_after":543113.0,"shares_owned_after_display":"543,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-27","scope":"insider"},{"id":5131909,"accession":"0000899243-21-020885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-020885","line_url":"/filing/0000899243-21-020885#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Revolution Medicines, Inc.","issuer_ticker":"RVMD","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"STARR KEVIN P; TEPPER ROBERT I; LEVIN MARK J; Third Rock Ventures GP II, L.P.; Third Rock Ventures II, L.P.; TRV GP II, LLC","owner_display_name":"STARR KEVIN P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135000.0,"shares_display":"135,000","price_per_share":30.93,"price_display":"30.93","price_state":"stated","total_value":4175550.0,"total_display":"4,175,550.00","total_whole":"4,175,550","shares_owned_after":1774317.0,"shares_owned_after_display":"1,774,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-27","scope":"insider"},{"id":4084642,"accession":"0000899243-21-020883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-020883","line_url":"/filing/0000899243-21-020883#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP II, L.P.; LEVIN MARK J; TRV GP II, LLC; Third Rock Ventures II, L.P.; TEPPER ROBERT I; STARR KEVIN P","owner_display_name":"Third Rock Ventures GP II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":552520.0,"shares_display":"552,520","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":4420160.0,"total_display":"4,420,160.00","total_whole":"4,420,160","shares_owned_after":5947829.0,"shares_owned_after_display":"5,947,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-27","scope":"insider"},{"id":5275866,"accession":"0000899243-21-009481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-009481","line_url":"/filing/0000899243-21-009481#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TEPPER ROBERT I; STARR KEVIN P; Third Rock Ventures II, L.P.; Third Rock Ventures GP II, L.P.; LEVIN MARK J; TRV GP II, LLC","owner_display_name":"TEPPER ROBERT I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1450000.0,"shares_display":"1,450,000","price_per_share":11.75,"price_display":"11.75","price_state":"stated","total_value":17037500.0,"total_display":"17,037,500.00","total_whole":"17,037,500","shares_owned_after":7750349.0,"shares_owned_after_display":"7,750,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2858132,"accession":"0000899243-20-031919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031919","line_url":"/filing/0000899243-20-031919#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"LEVIN MARK J; Third Rock Ventures II, L.P.; TEPPER ROBERT I; TRV GP II, LLC; STARR KEVIN P; Third Rock Ventures GP II, L.P.","owner_display_name":"LEVIN MARK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":7.005,"price_display":"7.00","price_state":"stated","total_value":105075.0,"total_display":"105,075.00","total_whole":"105,075","shares_owned_after":9200349.0,"shares_owned_after_display":"9,200,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2791128,"accession":"0000899243-20-031680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031680","line_url":"/filing/0000899243-20-031680#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Jounce Therapeutics, Inc.","issuer_ticker":"JNCE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"LEVIN MARK J; TRV GP II, LLC; STARR KEVIN P; TEPPER ROBERT I; Third Rock Ventures II, L.P.; Third Rock Ventures GP II, L.P.","owner_display_name":"LEVIN MARK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":7.2515,"price_display":"7.25","price_state":"stated","total_value":108772.5,"total_display":"108,772.50","total_whole":"108,773","shares_owned_after":9215349.0,"shares_owned_after_display":"9,215,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":4138777,"accession":"0000899243-17-025425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-025425","line_url":"/filing/0000899243-17-025425#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Allena Pharmaceuticals, Inc.","issuer_ticker":"ALNA","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"LEVIN MARK J; Third Rock Ventures GP II, L.P.; STARR KEVIN P; Third Rock Ventures II, L.P.; TRV GP II, LLC","owner_display_name":"LEVIN MARK J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215000.0,"shares_display":"215,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3010000.0,"total_display":"3,010,000.00","total_whole":"3,010,000","shares_owned_after":2790964.0,"shares_owned_after_display":"2,790,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-06","filed_date":"2017-11-06","scope":"insider"},{"id":4886750,"accession":"0000899243-17-022639","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-022639","line_url":"/filing/0000899243-17-022639#line-2","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP II, LLC; Third Rock Ventures GP II, L.P.; LEVIN MARK J; TEPPER ROBERT I; Third Rock Ventures II, L.P.","owner_display_name":"TRV GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":43.0,"price_display":"43.00","price_state":"stated","total_value":17200000.0,"total_display":"17,200,000.00","total_whole":"17,200,000","shares_owned_after":6885104.0,"shares_owned_after_display":"6,885,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-26","filed_date":"2017-09-27","scope":"insider"},{"id":4886744,"accession":"0000899243-17-022639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-022639","line_url":"/filing/0000899243-17-022639#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"TRV GP II, LLC; Third Rock Ventures GP II, L.P.; LEVIN MARK J; TEPPER ROBERT I; Third Rock Ventures II, L.P.","owner_display_name":"TRV GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201400.0,"shares_display":"201,400","price_per_share":43.0,"price_display":"43.00","price_state":"stated","total_value":8660200.0,"total_display":"8,660,200.00","total_whole":"8,660,200","shares_owned_after":7285104.0,"shares_owned_after_display":"7,285,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":4138711,"accession":"0000899243-17-021893","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-021893","line_url":"/filing/0000899243-17-021893#line-3","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP II, L.P.; LEVIN MARK J; Third Rock Ventures II, L.P.; TEPPER ROBERT I; TRV GP II, LLC","owner_display_name":"Third Rock Ventures GP II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":44.254,"price_display":"44.25","price_state":"stated","total_value":885080.0,"total_display":"885,080.00","total_whole":"885,080","shares_owned_after":57651.0,"shares_owned_after_display":"57,651","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-11","filed_date":"2017-09-12","scope":"insider"},{"id":4138709,"accession":"0000899243-17-021893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-021893","line_url":"/filing/0000899243-17-021893","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"MyoKardia Inc","issuer_ticker":"MYOK","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP II, L.P.; LEVIN MARK J; Third Rock Ventures II, L.P.; TEPPER ROBERT I; TRV GP II, LLC","owner_display_name":"Third Rock Ventures GP II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201250.0,"shares_display":"201,250","price_per_share":41.006207204968945,"price_display":"41.01","price_state":"stated","total_value":8252499.2,"total_display":"8,252,499.20","total_whole":"8,252,499","shares_owned_after":7487404.0,"shares_owned_after_display":"7,487,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-08","filed_date":"2017-09-12","scope":"insider","n_lines":2},{"id":4390523,"accession":"0000899243-17-006623","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-17-006623","line_url":"/filing/0000899243-17-006623","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures III, L.P.; Third Rock Ventures GP III, L.P.; STARR KEVIN P; Third Rock Ventures II, L.P.; TRV GP III, LLC; TRV GP II, LLC; TEPPER ROBERT I; LEVIN MARK J; Third Rock Ventures GP II, L.P.","owner_display_name":"Third Rock Ventures III, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2045294.0,"shares_display":"2,045,294","price_per_share":25.54423763722966,"price_display":"25.54","price_state":"stated","total_value":52245475.974,"total_display":"52,245,475.97","total_whole":"52,245,476","shares_owned_after":6475191.0,"shares_owned_after_display":"6,475,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-02","filed_date":"2017-03-06","scope":"insider","n_lines":5},{"id":4331904,"accession":"0000899243-17-003297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-003297","line_url":"/filing/0000899243-17-003297#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Blueprint Medicines Corp","issuer_ticker":"BPMC","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP II, L.P.; TRV GP II, LLC; LEVIN MARK J; TEPPER ROBERT I; Third Rock Ventures II, L.P.; STARR KEVIN P","owner_display_name":"Third Rock Ventures GP II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":35.275,"price_display":"35.28","price_state":"stated","total_value":35275000.0,"total_display":"35,275,000.00","total_whole":"35,275,000","shares_owned_after":4453753.0,"shares_owned_after_display":"4,453,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-09","scope":"insider"},{"id":2132323,"accession":"0000899243-16-033679","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-033679","line_url":"/filing/0000899243-16-033679","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Global Blood Therapeutics, Inc.","issuer_ticker":"GBT","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures II, L.P.; TEPPER ROBERT I; TRV GP II, LLC; TRV GP III, LLC; STARR KEVIN P; Third Rock Ventures III, L.P.; Third Rock Ventures GP II, L.P.; LEVIN MARK J; Third Rock Ventures GP III, L.P.","owner_display_name":"Third Rock Ventures II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000000.0,"shares_display":"2,000,000","price_per_share":19.36,"price_display":"19.36","price_state":"stated","total_value":38720000.0,"total_display":"38,720,000.00","total_whole":"38,720,000","shares_owned_after":9475191.0,"shares_owned_after_display":"9,475,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-14","filed_date":"2016-11-16","scope":"insider","n_lines":2},{"id":2625609,"accession":"0000899243-16-020304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-020304","line_url":"/filing/0000899243-16-020304#line-1","is_derivative":false,"issuer_cik":"0001180428","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001180428","owner_cik":null,"owner_name":"Third Rock Ventures GP II, L.P.; LEVIN MARK J; TRV GP II, LLC; Third Rock Ventures II, L.P.; TEPPER ROBERT I","owner_display_name":"Third Rock Ventures GP II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":850000.0,"shares_display":"850,000","price_per_share":31.25,"price_display":"31.25","price_state":"stated","total_value":26562500.0,"total_display":"26,562,500.00","total_whole":"26,562,500","shares_owned_after":3892916.0,"shares_owned_after_display":"3,892,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-16","filed_date":"2016-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001628171","name":"Revolution Medicines, Inc.","url":"/issuer/0001628171","role":"Ten percent owner","n_filings":2,"first_seen":"2021-05-27","last_seen":"2021-06-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001640455","name":"Jounce Therapeutics, Inc.","url":"/issuer/0001640455","role":"Ten percent owner","n_filings":4,"first_seen":"2020-11-19","last_seen":"2021-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001624658","name":"Allena Pharmaceuticals, Inc.","url":"/issuer/0001624658","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-06","last_seen":"2017-11-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001552451","name":"MyoKardia Inc","url":"/issuer/0001552451","role":"Ten percent owner","n_filings":2,"first_seen":"2017-09-12","last_seen":"2017-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001629137","name":"Global Blood Therapeutics, Inc.","url":"/issuer/0001629137","role":"Ten percent owner","n_filings":2,"first_seen":"2016-11-16","last_seen":"2017-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001597264","name":"Blueprint Medicines Corp","url":"/issuer/0001597264","role":"Ten percent owner","n_filings":1,"first_seen":"2017-02-09","last_seen":"2017-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Ten percent owner","n_filings":1,"first_seen":"2016-05-18","last_seen":"2016-05-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001614073","retrieved_at":"2026-08-23T19:13:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}